These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37438222)

  • 1. Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS).
    Heidenreich A; Paffenholz P; Hartmann F; Seelemeyer F; Pfister D
    Eur Urol Oncol; 2024 Feb; 7(1):122-127. PubMed ID: 37438222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST).
    Hiester A; Che Y; Lusch A; Kuß O; Niegisch G; Lorch A; Arsov C; Albers P
    Eur Urol; 2023 Jul; 84(1):25-31. PubMed ID: 36372627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma.
    Seelemeyer F; Pfister D; Pappesch R; Merkelbach-Bruse S; Paffenholz P; Heidenreich A
    Eur Urol Oncol; 2024 Jun; 7(3):319-322. PubMed ID: 37932157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
    Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
    J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II A/B Seminomas: A Systematic Review and Meta-Analysis.
    Melão BVLA; de Amorim LGCR; Sanches MR; Gomes GV; Gewehr DM; Moreira LHO; da Silva TP; Lobo MM; Bechara GR
    Int Braz J Urol; 2024; 50(4):415-432. PubMed ID: 38701185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience.
    Thor A; Negaard HFS; Grenabo Bergdahl A; Almås B; Melsen Larsen S; Lundgren PO; Gerdtsson A; Halvorsen D; Johannsdottir B; Jansson AK; Hellström M; Wahlqvist R; Langberg CW; Hedlund A; Akre O; Glimelius I; Ståhl O; Haugnes HS; Cohn-Cedermark G; Kjellman A; Tandstad T
    Eur Urol Open Sci; 2024 Jul; 65():13-19. PubMed ID: 38966804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy.
    Nicolai N; Nazzani S; Tesone A; Macchi A; Piva L; Salvioni R; Stagni S; Torelli T; Agostini E; Celso F; Giannatempo P; Procopio G; Avuzzi B; Lanocita R; Cattaneo L; Catanzaro M; Biasoni D
    Tumori; 2023 Aug; 109(4):379-386. PubMed ID: 35915559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum.
    Matulewicz RS; Benfante N; Funt SA; Feldman DR; Carver B; Doudt A; Knezevic A; Sheinfeld J
    J Urol; 2024 Jan; 211(1):80-89. PubMed ID: 37672753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
    Daneshmand S; Cary C; Masterson T; Einhorn L; Adra N; Boorjian SA; Kollmannsberger C; Schuckman A; So A; Black P; Bagrodia A; Skinner E; Alemozaffar M; Brand T; Eggener S; Pierorazio P; Stratton K; Nappi L; Nichols C; Luo C; Li M; Hu B
    J Clin Oncol; 2023 Jun; 41(16):3009-3018. PubMed ID: 36913642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary retroperitoneal lymph node dissection in testicular germ cell cancer in clinical stage IIA/B-renaissance of an established treatment?].
    Heidenreich J; Gößmann R; Seelemeyer F; Pfister D; Paffenholz P; Heidenreich A
    Urologie; 2024 Sep; ():. PubMed ID: 39269528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
    Tachibana I; Alabd A; Tong Y; Piroozi A; Mahmoud M; Kern SQ; Masterson TA; Adra N; Foster RS; Hanna NH; Einhorn LH; Cary C
    J Clin Oncol; 2023 Aug; 41(23):3930-3938. PubMed ID: 36730902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
    Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study.
    Abdul-Muhsin H; Rocco N; Navaratnam A; Woods M; L'Esperance J; Castle E; Stroup S
    World J Urol; 2021 Oct; 39(10):3833-3838. PubMed ID: 33959785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of primary retroperitoneal lymph node dissection in stage I and low-volume metastatic germ cell tumors.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D; Daneshmand S
    Curr Opin Urol; 2020 Mar; 30(2):251-257. PubMed ID: 31972635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical stage IIA/B seminoma - to do or not to do: the role of retroperitoneal lymphadenectomy].
    Heidenreich A; Seelemeyer F; Gößmann R; Heidenreich J; Pfister D
    Aktuelle Urol; 2024 Aug; ():. PubMed ID: 39089325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma.
    Hu B; Shah S; Shojaei S; Daneshmand S
    Clin Genitourin Cancer; 2015 Aug; 13(4):e265-e269. PubMed ID: 25682512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.
    Tabakin AL; Shinder BM; Kim S; Rivera-Nunez Z; Polotti CF; Modi PK; Sterling JA; Farber NJ; Radadia KD; Parikh RR; Kim IY; Saraiya B; Mayer TM; Singer EA; Jang TL
    Clin Genitourin Cancer; 2020 Apr; 18(2):e194-e201. PubMed ID: 31818649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.